AAAAAA

   
Results: 1-3 |
Results: 3
PHASE-II TRIAL OF THE USE OF MODIFIED BEP (BLEOMYCIN-B, ETOPOSIDE-E, CISPLATIN-P) AS A FIRST LINE TREATMENT OF ULTRA-HIGH-RISK (UHR) GESTATIONAL TROPHOBLASTIC TUMORS (GTT)
Authors: MURAD AM GUIMARAES RC ARAGAO BC SCALABRININETO AO
Citation: Am. Murad et al., PHASE-II TRIAL OF THE USE OF MODIFIED BEP (BLEOMYCIN-B, ETOPOSIDE-E, CISPLATIN-P) AS A FIRST LINE TREATMENT OF ULTRA-HIGH-RISK (UHR) GESTATIONAL TROPHOBLASTIC TUMORS (GTT), Annals of oncology, 9, 1998, pp. 325-325
PHASE-II MULTICENTRIC TRIAL OF NEOADJUVANT BLEOMYCIN, IFOSFAMIDE AND CARBOPLATIN (BIC) IN LOCALLY ADVANCED CERVICAL-CANCER
Authors: MURAD AM TRIGINELLI SA GUIMARAES RC ARAGAO BC GONCALVES OX LIMA LC
Citation: Am. Murad et al., PHASE-II MULTICENTRIC TRIAL OF NEOADJUVANT BLEOMYCIN, IFOSFAMIDE AND CARBOPLATIN (BIC) IN LOCALLY ADVANCED CERVICAL-CANCER, European journal of cancer, 33, 1997, pp. 930-930
PACLITAXEL(T) PLUS 5-FLUOROURACIL (5-FU) - A NOVEL AND VERY ACTIVE REGIMEN FOR ADVANCED GASTRIC-CANCER (AGC) - A PHASE-II TRIAL
Authors: MURAD AM GUIMARAES RC ARAGAO BC FERREIRA AF SCHWARTSMANN G BRUNDANI A
Citation: Am. Murad et al., PACLITAXEL(T) PLUS 5-FLUOROURACIL (5-FU) - A NOVEL AND VERY ACTIVE REGIMEN FOR ADVANCED GASTRIC-CANCER (AGC) - A PHASE-II TRIAL, European journal of cancer, 33, 1997, pp. 1255-1255
Risultati: 1-3 |